background image

US stocks keep grinding higher: what happens next and how to position with quality shares

Equities 5 minutes to read
Neil Wilson
Neil Wilson

Investor Content Strategist

Note: This is marketing material. This article is not investment advice, capital is at risk.

Key Points

  • Stock markets keep posting incremental record highs in what appears to be a classic late-cycle grind up
  • Volatility is compressed but conviction remains low, and investors are anticipating a change in the dynamic
  • Investors are questioning what this means for their portfolio and how to position for it

Wall Street continues to make record high finishes on low volatility – it has all the hallmarks of a late-cycle grind higher, with investors wondering two things: a) am I too late and b) am I being paid enough to take the risk?

The S&P 500 has not had a daily move of more than 1% since 22 August, and not seen a down day of more than 1% since the Liberation Day tariff deadline on 1 August. And apart from that wobble it’s remained above its 20-day moving average since April and has risen over 8% above the February highs.

Typically, the late-cycle investor faces a trade-off between participation and protection.

Here we are going to look into what’s happening, what could change and how you could position your portfolio.

Late Cycle Economic Dynamics

Each business cycle is different. But there are certain patterns that tend to repeat, reflecting things such as employment, inflation, corporate profits and so on.

Early cycle – sharp recovery from recession, fuelled usually by low interest rates and acceleration in demand.

Mid-cycle – moderate growth but sustained over a longer period.

Late cycle – activity peaks, growth slows and higher inflation and unemployment lower profits.

Recession – economic activity contracts, unemployment soars, profits fall, stocks tumble.

It’s debatable whether we are in the late-cycle phase post-Covid, but one can certainly make a strong case for it.

Since the initial post-pandemic boom we have seen a levelling off in growth and recent economic data points have indicated a peak has been reached and cooling is happening. Various leading indicators have softened notably this year and Fidelity says the US economy entered the late-cycle phase in Q3 of this year.

The Conference Board Leading Economic Index for the US declined by 0.5% in August 2025 to 98.4 and has been in steady decline for 3 years (chart 1), whilst a recession signal was triggered in August (chart 2).

 

 

LEI down
Chart 1. Source: The Conference Board
recession signal LEI

What Could Change

In terms of the stock market, a few things are possible to shift this dynamic.

Fed stops cutting: Inflation rises sharply, suggesting the Fed was too hasty to resume cutting in September. Leaving the central bank with no more room to cut, investors fret over stagflation.

Recession: The jobs picture in the US really is worse than it seems, the Fed was too late to ease and has to cut interest rates aggressively. This would likely push the market into at least a correction (-10%) and possible spark a new bear market. In 2001 (dotcom) and 2007 (financial crisis) the market bottomed long after the first rate cuts were made. In the dotcom bust the S&P 500 was down over 12% 12 months after the first cut, while in 2007 the broad market remained 22% down a year later. Three years after the 2001 recession cut the market was 14% down, while three years after the financial crisis cut of 2007 the market was 24% lower. 

AI bubble bursts: One bear thesis is that AI is in a bubble and it will burst, causing carnage among stock portfolios as the largest and most liquid assets get sold first.

Late-cycle investing: Positioning potential

Less cyclical, higher-quality shares are favoured in a late-cycle dynamic, such as healthcare and pharmaceuticals.

Pimco uses a system that selects companies based on their valuation adjusted for cash generation. This enables them to find high quality companies that also have good growth and trade at a discount on adjusted multiples. The other things they look for are low debt, high margins and strong free cash flow.

  • Stay invested, but be selective: Broad indices can still climb if earnings momentum is solid. Tilting towards quality growth (profitable, strong balance sheets, pricing power) avoids the most speculative parts of the market that get hit hardest when volatility snaps back.

  • Sector tilt: Defensives (healthcare, staples) can act as ballast, while cyclical leaders (tech, industrials) may still grind higher if the macro backdrop is stable.

  • Bonds / cash-like yields: With rates elevated, you don’thave to chase risk—short-dated Treasuries or gilts can yield 4–5% and provide a solid core if equities stumble.

  • Real assets / gold: If the “low vol” regime is partly driven by complacency around inflation or geopolitics, having some commodity or gold exposure hedges against a regime change and can capture upside momentum even if equities suffer.

Late cycle ETFs to consider

A couple of examples of ETFs that focus on quality shares. First the iShares MSCI World Quality Factor UCITS ETF (IWQU), which delivers a tilt to high ROE, stable earnings, low debt. It’s chock full of US tech with Nvidia, Apple and Microsoft its major holdings. The iShares Edge MSCI USA Quality Factor UCITS ETF (IUQA) also delivers exposure to US quality large caps. If you want to cut some US weight and go for European exposure, the iShares MSCI Europe Quality Dividend ESG UCITS ETF (EQDS) is one to consider for income generation.

Real assets – ie commodities: The iShares Diversified Commodity Swap UCITS ETF (ICOM)is a broad commodity basket, while the VanEck Gold Miners UCITS ETF (GDGB) offers straightforward exposure to gold via a non-complex instrument. I looked at investing in gold here.

Tilt to low beta equities: A low volatility ETF offering diversified exposure to developed companies and that seeks to minimise the market's peaks and valleys is the iShares MSCI World Minimum Volatility UCITS ETF (MVOL), which counts AT&T, Microsoft, Duke Energy and Motorola among its main holdings.

Defensive sector ETF: The SPDR MSCI World Health Care UCITS ETF (WHEA) offers global healthcare exposure with the likes of Eli Lilly, Johnson & Johnson, Abbvie and UnitedHealth among its main holdings.
You might also want to consider buffer ETFs, which limit the downside over a given timescale in return for investors agreeing to an upside cap.

If you are thinking a little more defensively, recently I took a look at the Ray Dalio All Weather portfolio.

Quarterly Outlook

01 /

  • Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Quarterly Outlook

    Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    Quarterly Outlook

    Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    John J. Hardy

    Global Head of Macro Strategy

    After the chaos of Q2, the quarter ahead should get a bit more clarity on how Trump 2.0 is impacting...
  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details. Past Performance is not indicative of future results.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992